Synergy CHC Corp. Proceeds from Debt, Net of Issuance Costs
Synergy CHC Corp. (SNYR) reported Proceeds from Debt, Net of Issuance Costs of $3.72 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-01.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromDebtNetOfIssuanceCosts · last filed 2026-04-01
- Synergy CHC Corp. proceeds from debt, net of issuance costs for the quarter ending 2025-12-31 was -$161.10K.
- Synergy CHC Corp. proceeds from debt, net of issuance costs for fiscal 2025 was $3.72M.
| Period end | Proceeds from Debt, Net of Issuance Costs | Proceeds from Debt, Net of Issuance Costs 3 month | Proceeds from Debt, Net of Issuance Costs 9 month | Proceeds from Debt, Net of Issuance Costs 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$161.10K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $3.72M 10-K · filed 2026-04-01 | ||
| 2025-09-30 | $3.88M 10-Q · filed 2025-11-13 | |||
| 2024-10-24 | $8.40M 10-K · filed 2026-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |